Skip to content
10-Q

Quarterly Report

Miromatrix Medical Inc.

0001558370-23-014834

← back to feed
Filed
Aug 14, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 9, 2023 27.31M sh
Shares Diluted Q2 2023 · Jun 30, 2023 27.25M sh
Shares Diluted Q2 2023 · Jun 30, 2023 24.9M sh
Shares Diluted Q2 2023 · Jun 30, 2022 20.62M sh
Shares Diluted Q2 2023 · Jun 30, 2022 20.55M sh
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$13.68M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$13.79M
Long Term Debt Q2 2023 · Jun 30, 2023 $386K
Long Term Debt Q2 2023 · Dec 31, 2022 $386K
Cash And Equivalents Q2 2023 · Jun 30, 2023 $4.57M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $5.21M
Cash And Equivalents Q2 2023 · Jun 30, 2022 $12.59M
Stockholders Equity Q2 2023 · Jun 30, 2023 $21.55M
Stockholders Equity Q2 2023 · Mar 31, 2023 $27.8M
Stockholders Equity Q2 2023 · Dec 31, 2022 $26.11M
Stockholders Equity Q2 2023 · Jun 30, 2022 $40.01M
Stockholders Equity Q2 2023 · Mar 31, 2022 $47.46M
Stockholders Equity Q2 2023 · Dec 31, 2021 $54.13M
Current Liabilities Q2 2023 · Jun 30, 2023 $3.89M
Current Liabilities Q2 2023 · Dec 31, 2022 $4.95M
Total Liabilities Q2 2023 · Jun 30, 2023 $6.9M
Total Liabilities Q2 2023 · Dec 31, 2022 $8.66M
Current Assets Q2 2023 · Jun 30, 2023 $21.88M
Current Assets Q2 2023 · Dec 31, 2022 $27.31M
Total Assets Q2 2023 · Jun 30, 2023 $28.45M
Total Assets Q2 2023 · Dec 31, 2022 $34.76M
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.24
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.56
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.40
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.75
Eps Basic Q2 2023 · Jun 30, 2023 −$0.24
Eps Basic Q2 2023 · Jun 30, 2023 −$0.56
Eps Basic Q2 2023 · Jun 30, 2022 −$0.40
Eps Basic Q2 2023 · Jun 30, 2022 −$0.75
Sga Expense Q2 2023 · Jun 30, 2023 $2.04M
Sga Expense Q2 2023 · Jun 30, 2023 $4.64M
Sga Expense Q2 2023 · Jun 30, 2022 $2.19M
Sga Expense restated Q2 2023 · Jun 30, 2022 $4.46M
Rd Expense Q2 2023 · Jun 30, 2023 $3.62M
Rd Expense Q2 2023 · Jun 30, 2023 $8.01M
Rd Expense Q2 2023 · Jun 30, 2022 $4.99M
Rd Expense restated Q2 2023 · Jun 30, 2022 $8.99M
Net Income Q2 2023 · Jun 30, 2023 −$6.53M
Net Income Q2 2023 · Jun 30, 2023 −$14.01M
Net Income Q2 2023 · Jun 30, 2022 −$8.18M
Net Income Q2 2023 · Jun 30, 2022 −$15.39M
Operating Income Q2 2023 · Jun 30, 2023 −$6.69M
Operating Income Q2 2023 · Jun 30, 2023 −$14.79M
Operating Income Q2 2023 · Jun 30, 2022 −$8.23M
Operating Income Q2 2023 · Jun 30, 2022 −$15.43M
Gross Profit Q2 2023 · Jun 30, 2023 −$116.48K
Gross Profit Q2 2023 · Jun 30, 2023 −$233.5K
Gross Profit Q2 2023 · Jun 30, 2022 −$121.05K
Gross Profit Q2 2023 · Jun 30, 2022 −$239.28K
Cost Of Revenue Q2 2023 · Jun 30, 2023 $125K
Cost Of Revenue Q2 2023 · Jun 30, 2023 $250K
Cost Of Revenue Q2 2023 · Jun 30, 2022 $125K
Cost Of Revenue Q2 2023 · Jun 30, 2022 $250K
Revenue Q2 2023 · Jun 30, 2023 $8.52K
Revenue Q2 2023 · Jun 30, 2023 $16.5K
Revenue Q2 2023 · Jun 30, 2022 $3.95K
Revenue Q2 2023 · Jun 30, 2022 $10.72K